Cancer Metabolism Training Program

癌症代谢培训计划

基本信息

  • 批准号:
    9766219
  • 负责人:
  • 金额:
    $ 21.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Cancer and metabolic dysfunction are closely related, and together they create unique therapeutic challenges. City of Hope (COH), an NCI-designated Comprehensive Cancer Center (COHCCC) located in Duarte, CA, is known internationally for clinical cancer research and groundbreaking diabetes research. Therefore, the Cancer Metabolism Training Program (CMTP), supported by a rapidly growing research infrastructure at COH, will bring together research experts in cancer and metabolism to train an elite group of dedicated postdoctoral fellows. The CMTP will focus on the link between cancer and metabolism, thereby connecting the long- standing COHCCC with the new COH Diabetes and Metabolism Research Institute. Faculty preceptors will direct research training in four primary areas: 1) Cancer Risk, Prevention, and Metabolism; 2) Cancer Metabolism Biology and Genetics; 3) Cancer Inflammation and Immune Cell Metabolism; and 4) Metabolism- Based Cancer Treatment. The training program includes an organized core curriculum consisting of courses in scientific and career development training, with individualized attention to best achieve each trainee’s personal goals and support the individual needs of a diverse trainee population. Courses in the Responsible Conduct of Research and Methods for Enhancing Reproducibility will also be required. Other associated activities include seminars, journal clubs, data clubs, and an annual Cancer Metabolism Day. The program is designed to take advantage of the existing institutional strengths, including well-established collaborations between cancer and diabetes/metabolism researchers. The CMTP has drawn 25 mentors from 12 departments, all of whom have robust funding profiles with high-profile publications, and are dedicated to preparing early career scientists for leadership roles in cancer research. Six promising early-career investigators will serve as co-mentors and participate in mentor development activities. The 3 NIH T32-supported postdoctoral trainees, supported for up to 3 years, will be selected through a rigorous process, including a personal interview. Trainees will be evaluated on their publications, applications for external funding, and participation in CMTP activities. The outstanding support from COH leadership includes 1) an additional trainee position for every underrepresented minority trainee recruited, up to a total of 6 positions; 2) salary supplementation for all CMTP trainees; 3) a stipend for research supplies; and 4) full administrative and faculty salary support. Each trainee will establish a Mentoring Committee, which will include a physician to expedite translational research. The CMTP leadership will include a Recruitment Committee to oversee national recruitment efforts, a Curriculum and Training Committee to oversee course development, an Executive Committee to evaluate and modify program components, and an Internal and External Advisory Board to independently assess program progress. The overall goal of the CMTP is to assist the transformation of promising researchers into strong independent, funded scientists with the capacity to make contributions that improve human health.
癌症和代谢功能障碍密切相关,它们共同创造了独特的治疗挑战。 City of Hope(COH)是一家位于加利福尼亚州杜阿尔特的NCI指定的综合癌症中心(COHCCC), 以临床癌症研究和开创性的糖尿病研究而闻名国际。因此 癌症代谢培训计划(CMTP),由COH快速增长的研究基础设施支持, 将汇集癌症和代谢方面的研究专家,培养一批敬业的博士后精英。 伙计们CMTP将重点关注癌症和代谢之间的联系,从而将长期的 与新的COH糖尿病和代谢研究所合作。教师将 在四个主要领域的直接研究培训:1)癌症风险,预防和代谢; 2)癌症 代谢生物学和遗传学; 3)癌症炎症和免疫细胞代谢;和4)代谢- 基于癌症治疗。培训计划包括一个有组织的核心课程,包括以下课程: 科学的职业发展培训,注重个性化,最大限度地实现每个学员的个人价值 目标,并支持不同学员群体的个人需求。负责任行为课程 还需要进行提高生殖能力的研究和方法。其他相关活动包括 研讨会,期刊俱乐部,数据俱乐部和一年一度的癌症代谢日。该计划旨在采取 利用现有的机构优势,包括癌症和癌症之间的良好合作, 糖尿病/代谢研究人员。CMTP从12个部门吸引了25名导师,他们都有 强大的资金概况与高调的出版物,并致力于准备早期的职业科学家, 在癌症研究中的领导作用。六名有前途的早期职业调查员将担任共同导师, 参与导师发展活动。3 NIH T32支持的博士后培训生,支持了 到3年,将通过严格的程序,包括个人面试选择。学员将 评估他们的出版物,申请外部资金,并参与CMTP活动。的 来自COH领导层的突出支持包括:1)为每一个代表性不足的人增加一个实习生职位 招聘少数族裔受训人员,最多共6个职位; 2)为所有CMTP受训人员提供工资补贴; 3)a 研究用品的津贴;和4)充分的行政和教师工资支持。每一位学员都将建立一个 指导委员会,其中将包括一名医生,以加快转化研究。CMTP领导层 将包括一个招聘委员会,以监督国家招聘工作,一个课程和培训 委员会监督课程开发,执行委员会评估和修改计划 组成部分,以及内部和外部咨询委员会独立评估计划进展情况。的 CMTP的总体目标是帮助有前途的研究人员转变为强大的独立, 资助有能力为改善人类健康做出贡献的科学家。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David K Ann其他文献

The role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cells
酪氨酸激酶 Etk/Bmx 在表皮生长因子诱导的 MDA-MB-468 乳腺癌细胞凋亡中的作用
  • DOI:
    10.1038/sj.onc.1207308
  • 发表时间:
    2003-12-15
  • 期刊:
  • 影响因子:
    7.300
  • 作者:
    Kai-Yun Chen;Li-Ming Huang;Hsing-Jien Kung;David K Ann;Hsiu-Ming Shih
  • 通讯作者:
    Hsiu-Ming Shih

David K Ann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David K Ann', 18)}}的其他基金

Core 1: Planning and Evaluation
核心1:规划与评估
  • 批准号:
    10762163
  • 财政年份:
    2023
  • 资助金额:
    $ 21.58万
  • 项目类别:
Fatty acids and their receptors-mediated tumor metastasis and progression
脂肪酸及其受体介导的肿瘤转移和进展
  • 批准号:
    10330011
  • 财政年份:
    2020
  • 资助金额:
    $ 21.58万
  • 项目类别:
Fatty acids and their receptors-mediated tumor metastasis and progression
脂肪酸及其受体介导的肿瘤转移和进展
  • 批准号:
    9916932
  • 财政年份:
    2020
  • 资助金额:
    $ 21.58万
  • 项目类别:
Fatty acids and their receptors-mediated tumor metastasis and progression
脂肪酸及其受体介导的肿瘤转移和进展
  • 批准号:
    10549362
  • 财政年份:
    2020
  • 资助金额:
    $ 21.58万
  • 项目类别:
Yes 2 Success
是 2 成功
  • 批准号:
    10573291
  • 财政年份:
    2018
  • 资助金额:
    $ 21.58万
  • 项目类别:
Cancer Metabolism Training Program
癌症代谢培训计划
  • 批准号:
    10481834
  • 财政年份:
    2018
  • 资助金额:
    $ 21.58万
  • 项目类别:
Yes 2 Success
是 2 成功
  • 批准号:
    10000862
  • 财政年份:
    2018
  • 资助金额:
    $ 21.58万
  • 项目类别:
Yes 2 Success
是 2 成功
  • 批准号:
    9788325
  • 财政年份:
    2018
  • 资助金额:
    $ 21.58万
  • 项目类别:
Yes 2 Success
是 2 成功
  • 批准号:
    10376723
  • 财政年份:
    2018
  • 资助金额:
    $ 21.58万
  • 项目类别:
FLOAT System to Study Salivary Gland Cancer Invasion
FLOAT 系统研究唾液腺癌侵袭
  • 批准号:
    9763563
  • 财政年份:
    2018
  • 资助金额:
    $ 21.58万
  • 项目类别:

相似海外基金

Spatio-temporal mechanistic modeling of whole-cell tumor metabolism
全细胞肿瘤代谢的时空机制模型
  • 批准号:
    10645919
  • 财政年份:
    2023
  • 资助金额:
    $ 21.58万
  • 项目类别:
Validation of imaging brain tumor metabolism using deuterated glucose
使用氘化葡萄糖验证脑肿瘤代谢成像
  • 批准号:
    10560260
  • 财政年份:
    2023
  • 资助金额:
    $ 21.58万
  • 项目类别:
Determining the relationship between tumor metabolism and nanoparticle accumulation
确定肿瘤代谢与纳米颗粒积累之间的关系
  • 批准号:
    575810-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 21.58万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism
脂肪因子信号传导作为肿瘤代谢的治疗靶向驱动因素
  • 批准号:
    10366023
  • 财政年份:
    2021
  • 资助金额:
    $ 21.58万
  • 项目类别:
Tumor Metabolism
肿瘤代谢
  • 批准号:
    10391399
  • 财政年份:
    2021
  • 资助金额:
    $ 21.58万
  • 项目类别:
Adipokine Signaling as a Therapeutically Targetable Driver of Tumor Metabolism
脂肪因子信号传导作为肿瘤代谢的治疗靶向驱动因素
  • 批准号:
    10580769
  • 财政年份:
    2021
  • 资助金额:
    $ 21.58万
  • 项目类别:
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC
通过 β-连环蛋白靶向肿瘤代谢和免疫环境:迈向 HCC 精准医疗
  • 批准号:
    10605197
  • 财政年份:
    2020
  • 资助金额:
    $ 21.58万
  • 项目类别:
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC
通过 β-连环蛋白靶向肿瘤代谢和免疫环境:走向 HCC 精准医疗
  • 批准号:
    10224895
  • 财政年份:
    2020
  • 资助金额:
    $ 21.58万
  • 项目类别:
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC
通过 β-连环蛋白靶向肿瘤代谢和免疫环境:迈向 HCC 精准医疗
  • 批准号:
    10027558
  • 财政年份:
    2020
  • 资助金额:
    $ 21.58万
  • 项目类别:
High-resolution volumetric imaging of metabolic activity in tissues and its application to tumor metabolism
组织代谢活动的高分辨率体积成像及其在肿瘤代谢中的应用
  • 批准号:
    10376225
  • 财政年份:
    2020
  • 资助金额:
    $ 21.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了